JPWO2020017629A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020017629A5 JPWO2020017629A5 JP2020531380A JP2020531380A JPWO2020017629A5 JP WO2020017629 A5 JPWO2020017629 A5 JP WO2020017629A5 JP 2020531380 A JP2020531380 A JP 2020531380A JP 2020531380 A JP2020531380 A JP 2020531380A JP WO2020017629 A5 JPWO2020017629 A5 JP WO2020017629A5
- Authority
- JP
- Japan
- Prior art keywords
- rgma
- ham
- inhibitor
- htlv
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022148180A JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2024061895A JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2025100449A JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018135925 | 2018-07-19 | ||
| JP2018135925 | 2018-07-19 | ||
| PCT/JP2019/028431 WO2020017629A1 (ja) | 2018-07-19 | 2019-07-19 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022148180A Division JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020017629A1 JPWO2020017629A1 (ja) | 2021-08-02 |
| JPWO2020017629A5 true JPWO2020017629A5 (cg-RX-API-DMAC7.html) | 2022-07-01 |
| JP7150286B2 JP7150286B2 (ja) | 2022-10-11 |
Family
ID=69163691
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020531380A Active JP7150286B2 (ja) | 2018-07-19 | 2019-07-19 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2022148180A Active JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2024061895A Active JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2025100449A Pending JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022148180A Active JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2024061895A Active JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
| JP2025100449A Pending JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Htlv-1関連脊髄症(ham)治療又は予防剤、及びhamの治療方法 |
Country Status (16)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2025070749A1 (cg-RX-API-DMAC7.html) * | 2023-09-29 | 2025-04-03 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1442749A1 (en) * | 2003-01-31 | 2004-08-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system |
| WO2005087268A1 (ja) * | 2004-03-11 | 2005-09-22 | Bioclues, Inc | 軸索再生促進剤 |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| CN102131571B (zh) | 2008-09-02 | 2014-03-05 | 东丽电池隔膜株式会社 | 微孔性高分子膜、该膜的制备方法及该膜作为电池隔膜的应用 |
| JP5552630B2 (ja) | 2008-10-24 | 2014-07-16 | 学校法人 聖マリアンナ医科大学 | Htlv−i関連脊髄症を治療または予防するための医薬、およびhtlv−i関連脊髄症の患者に対する抗体療法の効果を試験する方法 |
| KR102284780B1 (ko) | 2009-12-09 | 2021-08-02 | 미쓰비시 타나베 파마 코퍼레이션 | T 세포 활성화 저해제, 이것을 함유하는 의약 조성물 및 t 세포 활성화 저해 물질의 스크리닝 방법 |
| CA2824515C (en) * | 2011-01-18 | 2022-09-13 | Bioniz, Llc | Compositions and methods for modulating gamma-c-cytokine activity |
| JP5963233B2 (ja) * | 2011-12-07 | 2016-08-03 | 学校法人 聖マリアンナ医科大学 | Htlv−1関連脊髄症を治療または予防するための医薬および前記医薬を用いた抗体療法の治療効果の確認方法 |
| JP6310845B2 (ja) * | 2012-07-06 | 2018-04-11 | 学校法人 聖マリアンナ医科大学 | Htlv−1関連脊髄症患者の治療方法および治療剤 |
| WO2016038084A1 (en) | 2014-09-10 | 2016-03-17 | AbbVie Deutschland GmbH & Co. KG | Rgma fragment based diagnostic assay |
| CA2983898A1 (en) * | 2015-04-28 | 2016-11-03 | Mitsubishi Tanabe Pharma Corporation | Rgma binding protein and use thereof |
| WO2017189963A1 (en) * | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| TW202523689A (zh) * | 2016-06-01 | 2025-06-16 | 美商艾伯維有限公司 | 治療脊髓損傷及疼痛之方法 |
| US10772887B2 (en) * | 2016-08-03 | 2020-09-15 | Kagoshima University | Anti-HTLV-1 drug and therapeutic agent for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) |
-
2019
- 2019-07-19 PE PE2025002847A patent/PE20260298A1/es unknown
- 2019-07-19 CN CN202310983521.2A patent/CN116850291A/zh active Pending
- 2019-07-19 WO PCT/JP2019/028431 patent/WO2020017629A1/ja not_active Ceased
- 2019-07-19 SG SG11202100561QA patent/SG11202100561QA/en unknown
- 2019-07-19 CN CN202310983220.XA patent/CN116942831A/zh active Pending
- 2019-07-19 CN CN201980048012.2A patent/CN112566664B/zh active Active
- 2019-07-19 EP EP25202154.8A patent/EP4656657A3/en active Pending
- 2019-07-19 KR KR1020217005032A patent/KR20210034055A/ko not_active Ceased
- 2019-07-19 JP JP2020531380A patent/JP7150286B2/ja active Active
- 2019-07-19 TW TW108125746A patent/TWI825131B/zh active
- 2019-07-19 TW TW112142583A patent/TW202408577A/zh unknown
- 2019-07-19 AU AU2019306721A patent/AU2019306721B2/en active Active
- 2019-07-19 PE PE2021000080A patent/PE20211376A1/es unknown
- 2019-07-19 CA CA3112511A patent/CA3112511A1/en active Pending
- 2019-07-19 MX MX2021000732A patent/MX2021000732A/es unknown
- 2019-07-19 EP EP19838340.8A patent/EP3824907B1/en active Active
- 2019-07-19 BR BR112021000949-3A patent/BR112021000949A2/pt unknown
- 2019-07-19 CN CN202310983277.XA patent/CN116785439A/zh active Pending
- 2019-07-19 US US17/261,480 patent/US20210269535A1/en active Pending
-
2021
- 2021-01-18 IL IL280257A patent/IL280257A/en unknown
- 2021-01-18 PH PH12021550134A patent/PH12021550134A1/en unknown
- 2021-02-18 ZA ZA2021/01113A patent/ZA202101113B/en unknown
-
2022
- 2022-09-16 JP JP2022148180A patent/JP7475011B2/ja active Active
-
2024
- 2024-04-08 JP JP2024061895A patent/JP7703174B2/ja active Active
-
2025
- 2025-06-16 JP JP2025100449A patent/JP2025134820A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111601791A (zh) | Ezh2抑制剂及其药学上可接受的盐和多晶型物及其应用 | |
| CY1124257T1 (el) | N-[4-ΦΘOPO-5-[[(2S,4S)-2-MEΘYΛO-4-[(5-MEΘYΛO-1,2,4-ΟΞAΔIAZOΛ-3-YΛO)MEΘOΞY]-l-ΠΙΠΕΡΙΔΥΛΟ]ΜΕΘΥΛΟ]ΘΕΙΑΖΟΛ-2-ΥΛΟ]ΑΚΕΤΑΜΙΔΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ OGA | |
| SA521422143B1 (ar) | 15-pgdh مثبط | |
| EA202193015A1 (ru) | Ингибиторы cdk | |
| JP1735298S (ja) | 骨切り術用ウェッジ | |
| EA202090530A1 (ru) | Производные 1-бензил-2-имино-4-фенил-5-оксоимидазолидина как ингибиторы протеазы вич | |
| CN113412260A (zh) | 己酮糖激酶抑制剂及其用途 | |
| CN114072404A (zh) | Ret选择性抑制剂及其制备方法和用途 | |
| JP2016523260A5 (cg-RX-API-DMAC7.html) | ||
| EA202191188A1 (ru) | Бензамиды производных пиразолил-амино-пиримидинила, композиции на их основе и способы применения | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| MA45984B1 (fr) | Polytherapie pour la copd | |
| JP1735297S (ja) | 骨切り術用ウェッジ | |
| MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
| JP2021513972A5 (cg-RX-API-DMAC7.html) | ||
| IL193252A0 (en) | N-hydroxyacrylamide compounds | |
| CN109661395A (zh) | Pde4抑制剂 | |
| MX2019008181A (es) | Inhibidores selectivos hdac6, metodos de preparacion y aplicacion de los mismos. | |
| AR119159A1 (es) | Tratamientos de angioedema | |
| EA202190153A1 (ru) | Составы ингибитора axl/mer | |
| EA200801619A1 (ru) | Способ улучшения фармакокинетики ингибиторов интегразы вич (варианты), набор и фармацевтическая композиция (варианты) | |
| CN115666576A (zh) | 一种治疗和/或预防冠状病毒引发的疾病的化合物及其应用 | |
| EA202190452A1 (ru) | Ингибиторы cdk8/19 | |
| WO2020136298A3 (es) | Inhibidores de la caspasa 1 para uso en el tratamiento de la anemia | |
| CN115397411A (zh) | 药物组合及其用途 |